Fundraising Fox

Antiva Biosciences

Redwood City, US · Founded 2012 · Delaware corporation · 10 known investors

antivabio.com ↗

Antiva Biosciences develops a topical therapeutic for women with high-risk HPV infection and pre-cancerous cervical lesions, utilizing antiviral prodrug chemistry. The company targets an unmet clinical need where no approved therapeutic options currently exist.

BiotechFemTechHealthtechMedical Devicesin /antiva-biosciences-inc

Founders & leadership

GM
Gail MaderisDirector
KB
Kristine BallExecutive Officer, Director
EC
Elaine ChienExecutive Officer
SW
Sarah WalterExecutive Officer
RG
Raju GadirajuExecutive Officer
SJ
Steven JamesDirector
JS
John SaywardExecutive Officer
MC
Michael CannonDirector
WR
William RespessDirector
BR
Beni RovinskiDirector
FS
Florencia SegalDirector
BG
Brian GoodmanDirector

Investors · 10

Adjuvant CapitalNew York · $10M – $25M
Brace PharmaAtlanta
Canaan PartnersStamford · $500K – $20Mvia Wende Hutton · board
Lumira VenturesToronto · $1M – $10M
MPM BioImpactBoston · $1M – $15M
MPM Capital
OUP (Osage University Partners)Bala Cynwyd · $1M – $20M
Sofinnova VenturesMenlo Park · $100K – $15M
GaingelsreportedNew York · $200K – $500K
Osage University Partnersreported$1M – $20M

Reported raises · per SEC filings

Form D private placements
▶$38.5MraisedOct 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Clifford SamuelDirector
  • Beni RovinskiDirector
  • Florencia SegalDirector
  • Gail MaderisDirector
  • Kristine BallExecutive Officer, Director
  • Elaine ChienExecutive Officer
  • Brian GoodmanDirector
  • Wende HuttonDirector
  • Sarah WalterExecutive Officer
  • Raju GadirajuExecutive Officer
Offering amount
$53M
Amount sold
$38.5M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.6MraisedNov 2021 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gail MaderisExecutive Officer, Director
  • Clifford SamuelDirector
  • Oranee DanielsExecutive Officer
  • Steven JamesDirector
  • Benjamin RovinskiDirector
  • Raju GadirajuExecutive Officer
  • Sarah WalterExecutive Officer
  • Jenny YipDirector
  • Wende HuttonDirector
  • Vinzenz PloererDirector
  • David KabakoffDirector
Offering amount
$31M
Amount sold
$15.6M
First sale
Oct 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedJul 2018 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven P. JamesDirector
  • David Kabakoff, Ph.D.Director
  • Raju Gadiraju, Ph.D.Executive Officer
  • Michael D. CannonDirector
  • Wende S. HuttonDirector
  • Vinzenz PloererDirector
  • Gail MaderisExecutive Officer, Director
  • Oranee DanielsExecutive Officer
  • Benjamin RovinskiDirector
  • Ting JiaDirector
  • Sarah WalterExecutive Officer
Offering amount
$15M
Amount sold
$15M
First sale
Jul 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14.7MraisedAug 2017 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wendee S. HuttonDirector
  • Sarah WalterExecutive Officer
  • Benjamin RovinskiDirector
  • Raju Gadiraju, Ph.D.Executive Officer
  • Steven P. JamesDirector
  • David KabakoffDirector
  • Vinzenz PloererDirector
  • Gail MaderisExecutive Officer, Director
  • Oranee DanielsExecutive Officer
  • Michael D. CannonDirector
Offering amount
$25.9M
Amount sold
$14.7M
First sale
Feb 2017
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.9MraisedJun 2015 · 26 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steven JamesDirector
  • Wende HuttonDirector
  • John SaywardExecutive Officer
  • Michael CannonDirector
  • David KabakoffDirector
  • William RespessDirector
Offering amount
$16M
Amount sold
$8.9M
Proceeds to insiders
$18.3K
First sale
May 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news